AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35044802 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (MED)
Number of subjects: 0
Study 35044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental cost-effectiveness ratio for CABG compared with MED
Number of subjects: 0
Study 33259734 — intervention group
Group type: EXPERIMENTAL
Intervention: Yugengtongyu granules
Number of subjects: 114
Study 33259734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 33287711 — intervention group
Group type: EXPERIMENTAL
Intervention: CerebAir® EEG headset positioned by ICU physician
Number of subjects: 40
Study 33287711 — intervention group
Group type: COMPARATOR
Intervention: Simplified 8-electrodes-EEG recording positioned by EEG technician
Number of subjects: 40
Study 34488856 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education + craniocervical manual therapy and exercises
Number of subjects: 148
Study 34488856 — intervention group
Group type: COMPARATOR
Intervention: Craniocervical manual therapy and exercises
Number of subjects: 148
Study 35094487 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding transcatheter aortic valve replacement (TAVR)
Number of subjects: 27
Study 35190085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gufoni maneuver
Number of subjects: 48
Study 35190085 — intervention group
Group type: COMPARATOR
Intervention: Barbecue roll maneuver
Number of subjects: 48
Study 35190085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gufoni-Appiani maneuver
Number of subjects: 48
Study 35190085 — intervention group
Group type: COMPARATOR
Intervention: Zuma-e-Maia maneuver
Number of subjects: 48
Study 35190085 — intervention group
Group type: EXPERIMENTAL
Intervention: Single maneuver
Number of subjects: 48
Study 35190085 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple maneuvers (up to 4)
Number of subjects: 48
Study 35190085 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after one week
Number of subjects: 48
Study 33043411 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitally-enhanced 16-week social support pilot intervention including telephone counseling calls and Jawbone UP activity monitor.
Number of subjects: 30
Study 33043411 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitally-enhanced 16-week social support pilot intervention.
Number of subjects: 30
Study 35780488 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 111
Study 35780488 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 111
Study 34221076 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercises for 6 weeks
Number of subjects: 61
Study 34221076 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 61
Study 32618538 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood obesity prevention intervention group with nutrition education at family nights for parents and at school for children.
Number of subjects: 316
Study 32618538 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (parent workshops unrelated to nutrition).
Number of subjects: 316
Study 35753838 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous administration of EV71 vaccine and MR vaccine
Number of subjects: 680
Study 35753838 — intervention group
Group type: COMPARATOR
Intervention: Separate administration of EV71 vaccine
Number of subjects: 680
Study 35753838 — intervention group
Group type: COMPARATOR
Intervention: Separate administration of MR vaccine
Number of subjects: 680
Study 34389016 — intervention group
Group type: EXPERIMENTAL
Intervention: With drainage
Number of subjects: 100
Study 34389016 — intervention group
Group type: COMPARATOR
Intervention: Without drainage
Number of subjects: 100
Study 34062084 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlapping symptoms
Number of subjects: 4403
Study 34062084 — intervention group
Group type: COMPARATOR
Intervention: GERS only
Number of subjects: 4403
Study 34062084 — intervention group
Group type: COMPARATOR
Intervention: Dyspepsia only
Number of subjects: 4403
Study 32072685 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB + ABB (20% autogenous cortical bone and 80% anorganic bovine bone)
Number of subjects: 8
Study 32072685 — intervention group
Group type: COMPARATOR
Intervention: ACB + BP (20% autogenous cortical bone and 80% modified biphasic phycogenic material)
Number of subjects: 8
Study 32072685 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB + ABB
Number of subjects: 8
Study 32072685 — intervention group
Group type: COMPARATOR
Intervention: ACB + BP
Number of subjects: 8
Study 35367986 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered transdiagnostic psychological intervention
Number of subjects: 676
Study 35367986 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 676
Study 33972248 — intervention group
Group type: COMPARATOR
Intervention: Standard oral dose (10 mg/kg)
Number of subjects: 46
Study 33972248 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oral (35 mg/kg)
Number of subjects: 46
Study 33972248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (20 mg/kg)
Number of subjects: 46
Study 32762272 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg oral CBD
Number of subjects: 15
Study 32762272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 34714144 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut Snack (WS)
Number of subjects: 36
Study 34714144 — intervention group
Group type: EXPERIMENTAL
Intervention: Gummy Snack (GS)
Number of subjects: 36
Study 34714144 — intervention group
Group type: COMPARATOR
Intervention: No Snack (NS; control)
Number of subjects: 36
Study 34052004 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of adult-derived donor packed red blood cell (pRBC) units, n=9
Number of subjects: 16
Study 34052004 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of adult-derived donor packed red blood cell (pRBC) units, n=5
Number of subjects: 16
Study 34052004 — intervention group
Group type: COMPARATOR
Intervention: No transfusion, n=85 samples
Number of subjects: 16
Study 34052004 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-transfused patients), n=25
Number of subjects: 16
Study 33142450 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-enriched earthworm powder (SEP) 1.0 mg/kg
Number of subjects: 120
Study 33142450 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-enriched earthworm powder (SEP) 0.5 mg/kg
Number of subjects: 120
Study 33142450 — intervention group
Group type: EXPERIMENTAL
Intervention: Earthworm powder alone
Number of subjects: 120
Study 33142450 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 mg/kg Se)
Number of subjects: 120
Study 33075842 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model developed based on training set (n = 9,739) including maternal age, body mass index (BMI), cervical dilatation, and gestational age on admission.
Number of subjects: 19611
Study 33075842 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model predictions based on a subset of 18,803 patients.
Number of subjects: 19611
Study 34817388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention app 'Not Less But Better' for 20 days with five 4-day training modules.
Number of subjects: 232
Study 34817388 — intervention group
Group type: COMPARATOR
Intervention: Active control condition (digital detox treatment).
Number of subjects: 232
Study 35032350 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 0.4 ml/kg of plain bupivacaine 0.25%
Number of subjects: 40
Study 35032350 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound‐guided ESPB
Number of subjects: 40
Study 33524887 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151
Study 33524887 — intervention group
Group type: COMPARATOR
Intervention: Artificial sweetener ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151
Study 33524887 — intervention group
Group type: COMPARATOR
Intervention: Water ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151
Study 32000396 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiao-Qing-Long (XQL) decoction
Number of subjects: 112
Study 32000396 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 112
Study 32000396 — intervention group
Group type: EXPERIMENTAL
Intervention: XQL decoction
Number of subjects: 112
Study 36084200 — intervention group
Group type: EXPERIMENTAL
Intervention: iTAB + MI
Number of subjects: 255
Study 36084200 — intervention group
Group type: COMPARATOR
Intervention: iTAB
Number of subjects: 255
Study 32244933 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg trans-resveratrol twice daily for 12 months
Number of subjects: 129
Study 32244933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 34808597 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C-enriched collagen (hydrolyzed collagen [HC] + C; 20 g HC + 50 mg vitamin C)
Number of subjects: 50
Study 34808597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 g maltodextrin)
Number of subjects: 50
Study 33491396 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing with prior plaque disclosure
Number of subjects: 88
Study 33491396 — intervention group
Group type: COMPARATOR
Intervention: Air polishing without plaque disclosure
Number of subjects: 88
Study 33491396 — intervention group
Group type: COMPARATOR
Intervention: Rubber cup polishing without plaque disclosure
Number of subjects: 88
Study 33491396 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 88
Study 33491396 — intervention group
Group type: COMPARATOR
Intervention: Rubber cup polishing
Number of subjects: 88
Study 32151460 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy
Number of subjects: 0
Study 32151460 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35987776 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted PACE
Number of subjects: 48
Study 35987776 — intervention group
Group type: COMPARATOR
Intervention: PACE
Number of subjects: 48
Study 33677425 — intervention group
Group type: EXPERIMENTAL
Intervention: TetraGraph (TG)
Number of subjects: 120
Study 33677425 — intervention group
Group type: COMPARATOR
Intervention: TOFscan (TS)
Number of subjects: 120
Study 33446422 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen 60/30 mg (HDER)
Number of subjects: 21105
Study 33446422 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen 30/15 mg (LDER)
Number of subjects: 21105
Study 33076217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce AGEs intake
Number of subjects: 75
Study 33076217 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) control arm
Number of subjects: 75
Study 35876371 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced Stapler (RS)
Number of subjects: 199
Study 35876371 — intervention group
Group type: COMPARATOR
Intervention: Standard Stapler (SS)
Number of subjects: 199
Study 33112720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), 16-20 sessions
Number of subjects: 50
Study 33112720 — intervention group
Group type: COMPARATOR
Intervention: Attention Bias Modification (ABM), 8 sessions
Number of subjects: 50
Study 33112720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 50
Study 33112720 — intervention group
Group type: COMPARATOR
Intervention: Attention Bias Modification (ABM)
Number of subjects: 50
Study 35363563 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day caffeine
Number of subjects: 81
Study 35363563 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day caffeine
Number of subjects: 81
Study 35363563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 34759045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal local anesthesia (IPLA) with 0.2% ropivacaine
Number of subjects: 100
Study 34759045 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study 34759045 — intervention group
Group type: COMPARATOR
Intervention: Both groups (IPLA and control)
Number of subjects: 100
Study 32589613 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), n=33, duration: 3 months
Number of subjects: 63
Study 32589613 — intervention group
Group type: COMPARATOR
Intervention: Control group, n=30
Number of subjects: 63
Study 32589613 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), n=33
Number of subjects: 63
Study 35713753 — intervention group
Group type: COMPARATOR
Intervention: First-line chemotherapy in control arm of RCTs with immune checkpoint inhibitors (ICIs)
Number of subjects: 0
Study 35713753 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line chemotherapy in clinical practice (practice group)
Number of subjects: 0
Study 32767058 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy
Number of subjects: 100
Study 32456996 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermis fat arthroplasty
Number of subjects: 22
Study 32456996 — intervention group
Group type: COMPARATOR
Intervention: Gap arthroplasty
Number of subjects: 22
Study 32456996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 22
Study 35948408 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose in addition to guideline‐recommended therapy for HFrEF
Number of subjects: 0
Study 35948408 — intervention group
Group type: COMPARATOR
Intervention: Standard care for heart failure
Number of subjects: 0
Study 33068016 — intervention group
Group type: EXPERIMENTAL
Intervention: Family nursing conversations
Number of subjects: 51
Study 33068016 — intervention group
Group type: COMPARATOR
Intervention: Usual home health care
Number of subjects: 51
Study 35113479 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led healthy lifestyle intervention
Number of subjects: 21
Study 35113479 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (participants not achieving CVD risk reduction)
Number of subjects: 21
Study 33641195 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on melatonin (3 mg/day) with valproate (20 mg/kg in two divided doses)
Number of subjects: 104
Study 33641195 — intervention group
Group type: COMPARATOR
Intervention: Add-on placebo
Number of subjects: 104
Study 32791693 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA + EA + Usual care
Number of subjects: 36
Study 32791693 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 36
Study 35866202 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 essences over 4 weeks
Number of subjects: 80
Study 35866202 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 essences over 4 weeks
Number of subjects: 80
Study 33419704 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (500 pulses, 0.09 mJ/mm², twice a week for 6 weeks)
Number of subjects: 32
Study 33419704 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy
Number of subjects: 32
Study 33419704 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study 35613782 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF)
Number of subjects: 462
Study 35613782 — intervention group
Group type: COMPARATOR
Intervention: Placebo with breast milk
Number of subjects: 462
Study 35238917 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic
Number of subjects: 24
Study 35238917 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 24
Study 32366249 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT/FF 300/100
Number of subjects: 62
Study 32366249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 36207389 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine administration after tracheal intubation (Group N)
Number of subjects: 40
Study 36207389 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 40
Study 36207389 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine administration (Group N)
Number of subjects: 40
Study 32811786 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded sensory‐motor precision training
Number of subjects: 0
Study 32811786 — intervention group
Group type: COMPARATOR
Intervention: Sham-control
Number of subjects: 0
Study 32212258 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) gel, n = 30
Number of subjects: 60
Study 32212258 — intervention group
Group type: COMPARATOR
Intervention: Serum physiologic dressing, n = 30
Number of subjects: 60
Study 35353941 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) as a jumping gap graft material
Number of subjects: 20
Study 35353941 — intervention group
Group type: COMPARATOR
Intervention: Xenograft as a jumping gap filling material
Number of subjects: 20
Study 33775312 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin XR (500 mg daily increased to 1500 mg)
Number of subjects: 26
Study 33775312 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 26
Study 32770353 — intervention group
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin (pola)
Number of subjects: 0
Study 32684100 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial exploration strategy training (one brief session of 20-30 minutes)
Number of subjects: 40
Study 32218296 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking training with poles with an integrated resistance shock absorber (EG)
Number of subjects: 42
Study 32218296 — intervention group
Group type: COMPARATOR
Intervention: Training with classic poles (CG)
Number of subjects: 42
Study 34933570 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 2204
Study 34933570 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 2204
Study 32536000 — intervention group
Group type: EXPERIMENTAL
Intervention: CAVI (n=14) - transfemoral implantation of an Edwards Sapien XT valve into the inferior vena cava
Number of subjects: 28
Study 32536000 — intervention group
Group type: COMPARATOR
Intervention: OMT (n=14)
Number of subjects: 28
Study 36377973 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirtobrutinib
Number of subjects: 0
Study 36377973 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice of covalent BTK inhibitor
Number of subjects: 0
Study 33709661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with conventional Western medicine
Number of subjects: 145
Study 33709661 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 145
Study 33709661 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Electroacupuncture + Conventional vs Conventional)
Number of subjects: 145
Study 32583501 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD (Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 56
Study 32583501 — intervention group
Group type: COMPARATOR
Intervention: Regular Assessment Procedure (RAP)
Number of subjects: 56
Study 32583501 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD
Number of subjects: 56
Study 32583501 — intervention group
Group type: COMPARATOR
Intervention: RAP
Number of subjects: 56
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 32
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 32
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise followed by desmopressin
Number of subjects: 32
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin followed by exercise
Number of subjects: 32
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 32
Study 35839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin alone
Number of subjects: 32
Study 34952585 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary biopsychosocial rehabilitation (MBR)
Number of subjects: 223
Study 34952585 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study 33536119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the inter-sphincteric fistula tract plus platelet-rich plasma
Number of subjects: 98
Study 33536119 — intervention group
Group type: COMPARATOR
Intervention: Ligation of the inter-sphincteric fistula tract
Number of subjects: 98
Study 35073519 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitors
Number of subjects: 87
Study 34195642 — intervention group
Group type: EXPERIMENTAL
Intervention: Module-Based Training (MBT)
Number of subjects: 30
Study 34195642 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Learning (TL)
Number of subjects: 30
Study 34195642 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study 32792033 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training after a two-hour psychological first aid lecture
Number of subjects: 30
Study 32792033 — intervention group
Group type: COMPARATOR
Intervention: Two-hour psychological first aid lecture
Number of subjects: 30
Study 32792033 — intervention group
Group type: COMPARATOR
Intervention: Psychological first aid handout for individual study
Number of subjects: 30
Study 32493202 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of liver cirrhosis complications (medical and interventional)
Number of subjects: 0
Study 32493202 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 0
Study 32493202 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized treatments for HBV and HCV
Number of subjects: 0
Study 616285454 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education programme for osteoarthritis
Number of subjects: 100
Study 35561538 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral CBD
Number of subjects: 80
Study 35561538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34174778 — intervention group
Group type: EXPERIMENTAL
Intervention: CoVideo arm
Number of subjects: 15163